Roivant Sciences Ltd. ($ROIV)
Filing Information
| Accession Number | 0001140361-25-046786 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 30, 2025 |
| Document Date | Dec 23, 2025 |
| Document | View SEC Filing |
Transactions
6
Total Shares
1,138,378
Total Value
$7,841,752.65
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & Immunovant CEO | Common Shares | โ | Dec 23, 2025 | Exercise/Conversion | 313,841 | $3.85 | $1,208,287.85 | 1,811,749 | Direct | โ | View Details | |
President & Immunovant CEO | Common Shares | โ | Dec 23, 2025 | Sale | 200,000 | $22.45 | $4,490,000.00 | 1,611,749 | Direct | โ | View Details | |
President & Immunovant CEO | Common Shares | โ | Dec 24, 2025 | Exercise/Conversion | 117,848 | $3.85 | $453,714.80 | 1,729,597 | Direct | โ | View Details | |
President & Immunovant CEO | Common Shares | โ | Dec 24, 2025 | Sale | 75,000 | $22.53 | $1,689,750.00 | 1,654,597 | Direct | โ | View Details | |
President & Immunovant CEO | Stock Option (Right to Buy) | Derivative | Dec 23, 2025 | Exercise/Conversion | 313,841 | $0.00 | $0.00 | 5,562,682 | Direct | โ | View Details | |
President & Immunovant CEO | Stock Option (Right to Buy) | Derivative | Dec 24, 2025 | Exercise/Conversion | 117,848 | $0.00 | $0.00 | 5,444,834 | Direct | โ | View Details |